
Contextflow
Historical relationship · Exit labelled by APEX
Machine-learning analysis of chest CT scans for lung nodules, tissue patterns and longitudinal disease assessment.
Austria / Science-first ventures / Seed to Series A
Funding Now

Science-first venture capital for technologies with a defensible engineering or research foundation.
01 / The firm
APEX Ventures invests in early-stage companies whose technical foundations create a structural advantage. Its portfolio spans medical imaging, biotechnology, photonics, quantum technologies, computing, space systems, robotics and energy technology.
The current strategy focuses on seed to Series A companies, primarily in Europe, with initial investments of €0.5–2.5 million. APEX combines capital with support in technical assessment, commercial development and international networks.
APEX Ventures GmbH is based in Vienna and registered under FN 453159k. Austria's FMA lists the manager with its APEX Ventures, Digital Health, One Best in Class and Amadeus APEX Technology funds. These fund vehicles are part of one manager-level profile, not separate investors.
The Amadeus APEX Technology Fund is a partnership with Amadeus Capital Partners. Its joint investment committee includes representatives from both firms. The joint fund is not counted here as another independent investment platform.
02 / Portfolio
37 technical relationships from APEX's displayed portfolio, including three labelled exits. Five other relationships are separated below. Sector counts include the labelled technical exits. A displayed relationship does not establish present ownership.

Historical relationship · Exit labelled by APEX
Machine-learning analysis of chest CT scans for lung nodules, tissue patterns and longitudinal disease assessment.

Compact low-field MRI systems that remove cryogenics and support portable, open medical imaging.

AI image analysis for quantitative assessment of musculoskeletal and bone disease.

Digital-pathology AI that extracts tissue patterns and biomarkers for diagnostics and drug development.

Speech-analysis models and automated cognitive assessments designed to detect subtle impairment and Alzheimer’s-related pathology.

Quantitative medical-image analysis and radiomics models that extract imaging biomarkers.

Microrobotic platforms under development to diagnose, monitor and deliver treatment within brain tissue. The company states that the device is not FDA-cleared or CE-marked.

Computational pupillometry that measures pupil reactivity using a smartphone and compensates for ambient-light effects.

Rapid point-of-care blood testing using a combination of D-dimer and GFAP biomarkers to support stroke triage.

Plasma-catalytic reactors that convert carbon dioxide into chemical feedstocks and fuels.

Automated production of three-dimensional, load-path-oriented basalt-fiber reinforcement structures for construction.

Electric high-temperature industrial heating systems designed for processes up to 2,000°C.

Molecular-sieving membranes and engineered systems for energy-efficient industrial gas separation.

Electrostimulation hardware that controls electroactive microbes to improve carbon-to-fuel conversion in anaerobic digesters.

Confidential-computing systems that combine encrypted execution, attestation and key control across cloud infrastructure.

Proprietary FX AI architecture developed for learning and reasoning across language, time series and constraint-solving tasks.

Historical relationship · Exit labelled by APEX
Computer-vision and multimodal AI systems, including low-bit model quantization and efficient inference kernels. Its own site says its IP and core technology are now part of Dropbox.

Computer-vision object classifiers and metaclassifiers for forensic media analysis, with encoding-based training and semantic image search.

Rapidly tunable ultrafast laser systems for nonlinear microscopy, spectroscopy and stimulated Raman scattering imaging.

Miniaturized laser-beam-scanning display engines combining optical hardware and control software for augmented reality.

Integrated laser-illumination light engines for compact augmented-reality displays. The Quantum Light Chip is a product name, not evidence of quantum computing.

Computer-generated holography and optical display technology for three-dimensional imaging.

Reusable orbital transfer and return spacecraft with controlled atmospheric re-entry and payload recovery.

Flight-dynamics and space-situational-awareness software for orbital risk assessment, collision avoidance and satellite operations.

Thermal-infrared satellite constellation and wildfire-detection algorithms for space-based monitoring.

Microgravity research hardware, bioreactors and mission-integration systems for biological experiments in space.

Computational models of human cardiac tissue multiomics to identify cardiovascular disease mechanisms and drug targets.

RNA therapeutics research targeting dysregulated splicing and cellular senescence in age-related disease.

Liquid-nanoparticle therapeutics under development to carry oxygen and carbon dioxide across compromised tissue surfaces.

Autonomous mobile robots and fleet-orchestration software for bin retrieval and goods-to-person warehouse picking.

Machine-vision and robotic control systems for handling deformable textiles and other soft materials.

Historical relationship · Exit labelled by APEX
Machine-learning perception, sensor fusion and GPS-denied navigation software for autonomous drones and robots.
These five relationships are excluded from technical counts. Permissionless Technologies remains unconfirmed because the reviewed current public material does not establish its technical product.
Financial-crime compliance, transaction screening and due-diligence workflows. The reviewed material does not establish a distinct scientific or engineering breakthrough.
Historical relationship · Exit labelled by APEX
Music copyright administration, content monetization and licensing services. Excluded from technical counts.
Historical relationship · Exit labelled by APEX
Historical invoice-financing platform. APEX labels the relationship an exit and describes blockchain-based invoice lending; this does not establish a distinct technical breakthrough.
Drug-rebate analytics and value-based contracting software. Excluded from technical counts.
APEX describes Web3 privacy infrastructure, but the linked domain now presents a publishing page rather than verifiable technical product material. Technical qualification remains unconfirmed.
03 / People


Founder & General Partner
Technology investor and company builder, supporting technology strategy and international growth.

General Partner
Investment expertise in photonics, augmented reality, quantum technologies and technical IP evaluation.

Investment Partner
Quantum-physics background, with an investment focus on quantum technologies, future computing and AI infrastructure.

Principal
Investment and company-building background across health technology, life sciences and chemicals.
These Amadeus Capital Partners leaders serve on the Amadeus APEX Technology Fund investment committee. They are not APEX employees.

Investment Committee, Amadeus APEX Technology Fund
Amadeus Capital Partners co-founder and chief executive. Participates in the joint fund’s investment committee, not an APEX employee.

Investment Committee, Amadeus APEX Technology Fund
Amadeus Capital Partners co-founder. Participates in the joint fund’s investment committee, not an APEX employee.
04 / Connect
Founders raising a seed to Series A round can email APEX with a company summary, round size, timing and a PDF deck, as requested on its contact page.